Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is diagnosed by three criteria including cutaneous drug eruption, hematologic abnormalities, and systemic involvements. The hematologic abnormalities include presence of atypical lymphocytes or eosinophilia. The systemic involvements include lymphadenopathy, hepatitis, interstitial nephritis, interstitial pneumonia, or carditis. We experienced a 41-year-old female patient who presented DRESS syndrome at initial visit, but finally manifested with T-cell lymphoma. The patient complained of erythematous pruritic plaques with itching on her abdomen and thigh. There was no initiating factor and she was diagnosed with urticarial dermatitis. After treatment with antihistamine and systemic steroid, she recovered from skin lesion. However, 1 month later, she came to emergency department with aggravated skin lesion after taking nonsteroidal anti-inflammatory drug for 3 days. On admission, she showed a fever, skin rash, atypical lymphocytes in peripheral blood smear, and hepatitis. She was treated with systemic steroid under the impression of DRESS syndrome. Her symptoms began to improve, however, laboratory parameters were aggravated again. We performed bone-marrow biopsy because of her unusual progress. Finally she diagnosed with peripheral T-cell lymphoma and treated with allo-peripheral blood stem cell transplantation. In conclusion, we report a case of T-cell lymphoma which presented as DRESS syndrome. If patients with DRESS syndrome present lymphadenopathy and atypical lymphocytes, and do not respond to anti-inflammatory treatment, we should consider underlying lymphoproliferative disease. (Allergy Asthma Respir Dis 2013;1:280-283) 
INTRODUCTION
Cutaneous adverse drug reactions account for about 30% of all adverse drug reactions and are observed in 2-3% of hospitalized patients. [1] [2] [3] Severe cutaneous drug reactions include Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, and drug rash with eosinophilia and systemic symptoms syndrome (DRESS syndrome). 4, 5) The diagnosis of DRESS syndrome, named drug-induced pseudolymphoma or drug hypersensitivity syndrome in the past, proposed by Bocquet et al. 6) , is based on the following three criteria: 1) cutaneous drug eruption; 2) hematologic abnormalities, including eosinophilia ( >1.5×10 9 eosinophils/L) or the presence of atypical lymphocytes; and 3) systemic involvement, including adenopathies >2 cm in diameter, hepatitis (transaminase values >2 times normal), interstitial nephritis, interstitial pneumonia, or carditis. Histological evaluation of lymph nodes of the patients with DRESS syndrome often shows a lymphoma-like pattern and DRESS syndrome has been confused with malignant lymphoma. 7, 8) Cases in which DRESS syndrome presents with lymphoma are associated with a lower probability of malignancy, which is associated with atypical lymphocytes and necessitates consideration of skin or lymph node biopsies. 7, 8) We report here a case of T-cell lymphoma which presented as DRESS syndrome caused by non-steroidal anti-inflammatory drug (NSAID).
CASE REPORT
On July 3, 2012, a 41-year-old female patient visited our dermatology department for evaluation of an erythematous skin lesion with itching on her abdomen and both thighs. She had no history of allergy, including drug or food allergy. Moreover, she had no medical history. Erythematous pruritic plaques were scattered on both thighs and lasted for several days. The assessment of derma-tologists was urticarial dermatitis, and an antihistamine with systemic steroid (prednisolone 30 mg per day) was prescribed. During the following 1 month, her skin lesion improved until she started taking additional medication, including naproxen, due to myalgia that developed after she climbed a mountain. She stopped taking naproxen 3 days later because her skin rash worsened. After 2 days not taking the drugs, her myalgia recurred and she took another medication containing dexibuprofen. One day later, she visited an emergency department because the skin rash had spread over her whole body and she had facial edema (Fig. 1 ). The initial assessment was that she was suffering from drug eruption caused by NSAIDs.
On admission, her vital signs were a blood pressure of 100/60 mmHg, a heart rate of 96 beats/min, a respiratory rate of 14 breaths/ min, and a body temperature of 39.1°C. Confluent erythematous swollen maculopapaules over her whole body and lymphadenopathies in cervical and inguinal areas were found upon physical examination. All of the lymph nodes were nontender, firm, and sized less than 1 cm in diameter. Laboratory test results were as follows:
hemoglobin (Hb), 9.5 g/dL; white blood cells, 10,900/mm 3 (seg- To rule out underlying lymphoid malignancies, a bone marrow biopsy was performed. The bone marrow biopsy revealed interstitial infiltration by neoplastic cells positive for CD3, CD4, CD5, CD7, CD8, CD38, and human leukocyte antigens-DR (Fig. 2) . Her final diagnosis was T-cell lymphoma which presented as DRESS syndrome. After four cycles of chemotherapy, she was treated with allo-peripheral blood stem cell transplantation on December 21, 2012
and was discharged without any sequelae. No evidence of recurrence or skin lesion to date has been noted.
DISCUSSION
Our patient fulfilled the DRESS syndrome diagnostic criteria proposed by Bocquet et al. 
